Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
A Primer on PAMA
The impending legislation that may determine Medicare lab fees from 2025 onward
Targeting Group A Streptococcus for System Improvement
This webinar highlights internal processes regarding diagnostics for Group A Streptococcus, and explains how these results benefit patients, providers, and staff
Three Effective Mantras from Leading Lab Recruiters
This webinar offers expert insight and advice on how adaptability helps lab staffers find suitable candidates for their organizations
Clinical Lab Automation: Trends, Challenges, and Benefits
This webinar examines the adoption of automation technologies within clinical laboratories, and offers resources to leverage lab automation's transformative potential in healthcare settings
Diagnosing Billing Inefficiencies Impacting Laboratory Revenue
This webinar will reveal how audits turn actionable data into operational efficiencies and opportunities for improvement, which improves the financial health and sustainability of your laboratory
April 2024 Labs in Court
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Billing and Coding: The Secrets of Effective Queries
Formulating queries that are compliant, informative, and effective—even in tricky situations.
AI Pilot Program Proposed to Detect Medicare Fraud
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.
Championing Change
How clinical laboratory professionals can advocate for legislative and regulatory improvements
Expert Q&A: What’s New with PAMA and SALSA?
Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.
